Cutaneous aspergillosis in a lung transplant recipient

被引:8
|
作者
Ramos, A. [1 ,2 ]
Ussetti, P. [3 ]
Laporta, R. [3 ]
Lazaro, M. T. [3 ]
Sanchez-Romero, I. [4 ]
机构
[1] Univ Autonoma Madrid, Med Interna Serv, Hosp Univ Puerta de Hierro, Dept Internal Med, Madrid 28222, Spain
[2] Univ Autonoma Madrid, Spanish Network Res Infect Dis REIPI, Hosp Univ Puerta de Hierro, Madrid 28222, Spain
[3] Univ Autonoma Madrid, Dept Pneumol, Hosp Univ Puerta de Hierro, Madrid 28222, Spain
[4] Univ Autonoma Madrid, Dept Microbiol, Hosp Univ Puerta de Hierro, Madrid 28222, Spain
关键词
Aspergillus fumigatus; skin diseases; cutaneous infections; lung transplantation; INVASIVE ASPERGILLOSIS; AMPHOTERICIN-B; INFECTION; VORICONAZOLE; SPECTRUM; FUNGI; USTUS;
D O I
10.1111/j.1399-3062.2009.00423.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>Organ transplant recipients are at increased risk for Aspergillus infections. Cutaneous aspergillosis (CA) occurs less frequently and is poorly characterized. The case of a lung transplant recipient with CA is presented. Six months after transplantation, 3 painful skin nodules appeared, with 1 each in the right calf, left arm, and upper back. Exudate from the leg nodule yielded Aspergillus fumigatus. Computed tomography of the chest showed bilateral hilar lymphadenopathy, but < 1 cm in size. The case could be the result of Aspergillus dissemination from a hypothetical asymptomatic pulmonary infection. The lack of lung radiological signs could be related to prophylactic treatment with inhaled liposomal amphotericin B, which could have prevented clinically evident Aspergillus lung infection. The patient was treated with voriconazole, which was maintained for 3 months. The patient recovered completely.
引用
收藏
页码:471 / 473
页数:3
相关论文
共 50 条
  • [1] Tracheobronchial Aspergillosis following Primary Cutaneous Aspergillosis in a Lung-Transplant Recipient
    Cho, Woo Hyun
    Kim, Ji Eun
    Jeon, Doo Soo
    Kim, Yun Seong
    Chin, Hyun Woo
    Shin, Dong Hoon
    INTERNAL MEDICINE, 2011, 50 (02) : 131 - 134
  • [2] Primary cutaneous cryptococcosis in a lung transplant recipient
    Baumgarten, KL
    Valentine, VG
    Garcia-Diaz, JB
    SOUTHERN MEDICAL JOURNAL, 2004, 97 (07) : 692 - 695
  • [3] Invasive Pulmonary Aspergillosis with Exclusive Pleural Involvement in a Lung Transplant Recipient
    Garcia-Martin, Sergio
    Mora-Cuesta, Victor M.
    Naranjo-Gozalo, Sara
    Jimenez-Velasco, Jose Javier
    Roiz-Mesones, Maria Pia
    Fernandez-Lobo, Victor
    PROGRESS IN TRANSPLANTATION, 2024, 34 (1-2) : 53 - 54
  • [4] Pituitary aspergillosis in a kidney transplant recipient and review of the literature
    Vijayvargiya, P.
    Javed, I.
    Moreno, J.
    Mynt, M. A.
    Kotapka, M.
    Zaki, R.
    Ortiz, J.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (05) : E196 - E200
  • [5] A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient
    Walia, R.
    Montoya, J. G.
    Visvesvera, G. S.
    Booton, G. C.
    Doyle, R. L.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (01) : 51 - 54
  • [6] Cardiac invasive aspergillosis in a heart transplant recipient
    Eworo, Alia
    Munoz, Patricia
    Yanez, Juan F.
    Palomo, Jesus
    Guembe, Pedro
    Roda, Jorge
    Valerio, Maricela
    Guinea, Jesus
    Bouza, Emilio
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2011, 28 (03): : 134 - 138
  • [7] Prostatic aspergillosis in a renal transplant recipient
    Kaplan-Pavlovcic, S
    Masera, A
    Ovcak, Z
    Kmetec, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (07) : 1778 - 1780
  • [9] Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient
    Ramos, A.
    Segovia, J.
    Gomez-Bueno, M.
    Salas, C.
    Lazaro, M. T.
    Sanchez, I.
    Pulpon, L.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (01) : 60 - 63
  • [10] Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis
    Thomas, A.
    Korb, V.
    Guillemain, R.
    Caruba, T.
    Boussaud, V.
    Billaud, E.
    Prognon, P.
    Begue, D.
    Sabatier, B.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (01) : 49 - 53